EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study

Belen Kornfeld, Ahmed Taha, Lee Kyang, Hao-Wen Sim, Suzannah Dewhurst, Rachael McCloy, Vanessa Chin, Peter Earls, Andrew Parker, Brett Leavers, Dion Forstner, Peter Floros und 2 weitere

Journal of Robotic Surgery · 2024

DOI: 10.1007/s11701-024-01910-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Robotic Surgery, 2024. Verfasst von Belen Kornfeld und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, St. Vincent's Hospital, 390 Victoria St, Darlinghurst, NSW, 2010, Australia. belenkornfeld@gmail…. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Notre Dame Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present a cohort review of TORS resection for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) and its associated oncological outcomes spanning a 10-year period. A retrospective case series review was performed of patients undergoing primary surgical treatment for HPV-associated OPSCC through the St. Vincent’s Head and Neck Cancer service from 2011 to 2022. The primary outcomes were to investigate complete resection of the primary tumour, rates of recurrence, and survival analysis. Secondary outcomes included complications, rates of adjuvant therapy, sites of recurrence and rates of percutaneous endoscopic gastrostomy (PEG). 184 patients underwent TORS-based therapy with neck dissection, and guideline-directed adjuvant therapy for HPV-associated OPSCC. Our median follow-up was 46 months. The positive margin rate on final histopathology analysis was 10.9%. Adjuvant therapy was indicated in 85 patients (46%). The local recurrence rate was 10.9% with the majority (80%) of patients recurring in the first 3 years since treatment. The disease-specific survival at 3 years was 98.6% and at 5 years was 94.4%. The 3-year and 5-year OS for the cohort was 96.7% and 92.5%, respectively. The presence of extranodal extension and positive margins were associated with increased risk of recurrence, whereas adjuvant therapy was found to be a protective factor for both overall recurrence and survival. Major complications occurred in 12 patients (6.5%), resulting in one death. This study has demonstrated that primary surgical therapy for HPV-associated OPSCC is a safe and effective treatment modality with low local recurrence and complication rates, and overall survival benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresOropharyngeal NeoplasmsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment OutcomeNeoplasm Recurrence, LocalAustraliaAdultPapillomavirus InfectionsCarcinoma, Squamous CellMargins of ExcisionSquamous Cell Carcinoma of Head and NeckNeck DissectionAged, 80 and over

Stichwörter der Autor:innen

HPV-positive head and neck cancerNeck dissectionOncological outcomesOropharyngeal cancerPercutaneous gastrostomyTransoral robotic surgery

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, St. Vincent's Hospital, 390 Victoria St, Darlinghurst, NSW, 2010, Australia. belenkornfeld@gmail.com.
  • Faculty of Medicine and Health, University of New South Wales, High St, Sydney, NSW, 2052, Australia. belenkornfeld@gmail.com.
  • Department of Medicine, Notre Dame University, Sydney, NSW, 2010, Australia. belenkornfeld@gmail.com.
  • Department of Otolaryngology, Head and Neck Surgery, St. Vincent's Hospital, 390 Victoria St, Darlinghurst, NSW, 2010, Australia.
  • Faculty of Medicine and Health, University of New South Wales, High St, Sydney, NSW, 2052, Australia.
  • The Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.

Förderung

  • The University of Notre Dame Australia

Zitieren

APA

Kornfeld, B., Taha, A., Kyang, L., Sim, H. W., Dewhurst, S., McCloy, R., Chin, V., Earls, P., Parker, A., Leavers, B., Forstner, D., Floros, P., Crawford, J., & Gallagher, R. (2024). Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study. Journal of Robotic Surgery. https://doi.org/10.1007/s11701-024-01910-0

Vancouver

Kornfeld B, Taha A, Kyang L, Sim HW, Dewhurst S, McCloy R, et al. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study. Journal of Robotic Surgery. 2024. doi:10.1007/s11701-024-01910-0

BibTeX
@article{Kornfeld2024,
  author = {Kornfeld, Belen and Taha, Ahmed and Kyang, Lee and Sim, Hao-Wen and Dewhurst, Suzannah and McCloy, Rachael and Chin, Vanessa and Earls, Peter and Parker, Andrew and Leavers, Brett and Forstner, Dion and Floros, Peter and Crawford, Julia and Gallagher, Richard},
  title = {Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study},
  journal = {Journal of Robotic Surgery},
  year = {2024},
  doi = {10.1007/s11701-024-01910-0}
}
Kostenlos starten →